|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Derma Sciences, Inc. (DSCI) Announces Licensing Agreement with C-Boot Ltd to Market MOBILITY-1 for Treatment of Vascular Diseases
3/28/2007 12:33:54 PM
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (OTCBB: DSCI), a manufacturer and full line supplier of wound and skin care products, today announced that it has obtained a licensing agreement with C-Boot LTD, a medical biosystems company based in Israel, for the marketing, sales and distribution rights of C-Boot’s patented advanced therapeutic devices for the treatment of Chronic Venous Insufficiency (CVI), Deep Vein Thrombosis (DVT) prevention, venous ulcers, lymphedema, and other conditions that require compression therapy, including the enhancement of blood circulation during recovery from coronary artery bypass graft surgery and orthopedic hip and knee replacements. C-Boot’s products, which will be marketed by Derma Sciences under the MOBILITY-1TM brand, include a lightweight wearable dynamic compression device that periodically inflates and deflates thereby producing segmented and therapeutically significant compression. The technologies inherent within the device are covered by several US patents.
|
|
|
|
|
|
|
|
|
|
|